Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006, 150(2):275-278 | DOI: 10.5507/bp.2006.041

SCREENING FOR CHROMOSOMAL ANOMALIES IN THE FIRST TRIMESTER: A REPORT ON THE FIRST YEAR OF PROSPECTIVE SCREENING FOR CHROMOSOMAL ANOMALIES IN THE FIRST TRIMESTER IN THE CZECH REPUBLIC

Ishraq Dhaifalaha, Jiri Santavya, Jana Zapletalovab
a Department of Medical Genetics and Fetal Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
b Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc

Background: The increase in maternal age in recent years has intensified the effort to develop early non-invasive methods for screening for trisomy 21 and other chromosomal abnormalities in prenatal diagnosis. In the first trimester of pregnancy, maternal age, fetal nuchal translucency (NT), maternal levels of free β- human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A) are used as screening markers. We evaluated the introduction of this method of screening for the first time in the Czech Republic.

Methods: it is a prospective study for one-year from the beginning of 2004. The risk of trisomy 21(Down's syndrome) was estimated for 686 singleton pregnancies. The specific risk was calculated using the Fetal Medicine Foundation software (FMF) by accredited sonographers. Karyotyping was offered to women with risk ≥ 1 in 250.

Results: In the population screened 18 % of women were aged 35 and more. We found 2 cases of trisomy 21 and 1 case of trisomy 18 (Edward syndrome) resulting in a detection rate of 100 % for trisomy 21 for a 5 % false positive rate (33 of 683). The maternal age of the detected cases was 30, 38 and 42 years.

Conclusion: Introduction of the first trimester screening to our clinic, reduced the number of invasive genetic testing from 18 % to 5 %. First trimester screening for trisomy 21 and other aneuploidies has a high sensitivity with a low false positive rate and can be delivered in an efficient manner in a university hospital.

Keywords: First trimester screening, Nuchal translucency, Pregnancy-associated plasma protein-A (PAPP-A), Free ß-human

Received: April 28, 2006; Accepted: November 1, 2006; Published: December 1, 2006Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Dhaifalah, I., Santavy, J., & Zapletalova, J. (2006). SCREENING FOR CHROMOSOMAL ANOMALIES IN THE FIRST TRIMESTER: A REPORT ON THE FIRST YEAR OF PROSPECTIVE SCREENING FOR CHROMOSOMAL ANOMALIES IN THE FIRST TRIMESTER IN THE CZECH REPUBLIC. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.150(2), 275-278. doi: 10.5507/bp.2006.041
Download citation

References

  1. Nicolaides KH. Nuchal translucency and other first trimester sonographic markers of chromosomal abnormalities. AJOG 2004; 191:45-67. Go to original source... Go to PubMed...
  2. Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH. Integrated ultrasound and biochemical screening for trisomy 21 at 11 to 14 weeks. Prenat Diagn 2003; 23:306-10. Go to original source... Go to PubMed...
  3. Spencer K, Spencer C, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: A review of three years prospective experience. Br J Obstet Gynaecol 2003; 110:281-6. Go to original source... Go to PubMed...
  4. Schuchter K, Hafner E, Stangl G, Metzenbauer M, Hofinger D, Philipp K. The first trimester combined test for the detection of Trisomy 21e pregnancies in 4939 unselected pregnancies. Prenat Diagn 2002; 22:211-5. Go to original source... Go to PubMed...
  5. Wapner R, Thom E, Simpson J, Pergament E, Silver R, Filkins K. First trimester maternal serum biochemistry and fetal nuchal translucency screening (BUN) study group. First trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349:1405-13. Go to original source... Go to PubMed...
  6. Fetal Medicine Foundation www.fetalmedicine.com. Downs screening at 11-14 weeks.
  7. Sundberg K, Bang J, Smidt-Jensen S, Brocks V, Lundsteen C, Parner J. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 1997; 350:697-703. Go to original source... Go to PubMed...
  8. CEMAT Group. Randomised trial to assess safety and fetal outcome of early and mid-trimester amniocentesis. Lancet 1998; 351:242-7. Go to original source... Go to PubMed...
  9. Snijders R, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk for trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1999; 18:519-521. Go to original source...
  10. Snijders R, Brizot M, Faria M, Nicolaides KH (1995) Fetal exomphalos at 11-14 weeks of gestation. J Ultrasound Med 14:569- 574. Go to original source... Go to PubMed...
  11. Johnson S, Sebire N, Snijders R, Tunkel S, Nicolaides KH. Ultrasound screening for anencephaly at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1996; 9:14-16. Go to original source... Go to PubMed...
  12. Nicolaides KH, Campbell S, Gabbe S, Guidetti R. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet 1986; 2:72-74. Go to original source... Go to PubMed...
  13. Snijders R, Nicolaides KH. Sequential screening. In: Nicolaides KH, editor. Ultrasound Markers for Fetal Chromosomal Defects. Carnforth, UK: Parthenon Publishing, 1996. p. 109-13.
  14. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free ß-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13:231-7. Go to original source... Go to PubMed...
  15. Wald N, Kennard A, Hackshaw A , McGuire A. Antenatal screening for Downs syndrome. Health Technol Assess 1998; 2, 1-112. Go to original source...
  16. Grudzinskas J, Ward R. Screening for Trisomy 21e in the First Trimester. RCOG, 1997; 67-79.
  17. Cuckle H, Lith J. Appropriate biochemical parameters in first trimester screening for Trisomy 21e. Prenat Diagn 1999; 19:505- 512. Go to original source... Go to PubMed...